Contact Us
Digital Therapeutics For Fibromyalgia Global Market Report 2025
Global Digital Therapeutics For Fibromyalgia Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : November 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Digital Therapeutics For Fibromyalgia Global Market Report 2025

By Product Type (Software Applications, Devices, Platforms), By Therapy Area (Cognitive Behavioral Therapy, Mindfulness-Based Interventions, Pain Management, Other Therapy Types), By Distribution Channel (Online, Offline), By Application (Chronic Pain Management, Sleep Disorders, Fatigue Management, Other Applications), By End-User (Hospitals, Clinics, Homecare, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Digital Therapeutics For Fibromyalgia Market Overview

• Digital Therapeutics For Fibromyalgia market size has reached to $0.98 billion in 2024

• Expected to grow to $2.54 billion in 2029 at a compound annual growth rate (CAGR) of 20.9%

• Growth Driver: The Growing Awareness Of Digital Health Solutions Is Fueling The Growth Of The Market Due To Government-Backed Promotion And Widespread Adoption Of Official Health Apps

• Market Trend: Prescription-Based Digital Therapeutics And Remote Monitoring For Enhanced Treatment

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Digital Therapeutics For Fibromyalgia Market?

Digital therapeutics for fibromyalgia are health apps and online programs that deliver structured therapy and track symptoms to support day-to-day self-management. Its purpose is to ease pain and fatigue, improve sleep and function, and give patients and clinicians useful data to personalize care.

The main product types of digital therapeutics for fibromyalgia are software applications, devices, and platforms. Software applications refer to clinically validated programs designed to provide therapeutic interventions for managing fibromyalgia symptoms, including pain and fatigue. These solutions are distributed through online and offline channels. Key applications include chronic pain management, sleep disorders, fatigue management, and others, with primary end users being hospitals, clinics, homecare, and others.

Digital Therapeutics For Fibromyalgia Market Size and growth rate 2025 to 2029: Graph

What Is The Digital Therapeutics For Fibromyalgia Market Growth Forecast?

The digital therapeutics for fibromyalgia market size is expected to see exponential growth in the next few years. It will grow to $2.54 billion in 2029 at a compound annual growth rate (CAGR) of 20.9%. The growth in the forecast period can be attributed to expansion of reimbursement for evidence-based digital interventions, rising integration into rheumatology and primary care pathways, rising prevalence and symptom burden in aging populations, greater focus on women’s health and chronic pain equity, and cost-containment pressure to reduce unnecessary imaging and visits. Major trends in the forecast period include prescription digital therapeutics delivering acceptance and commitment therapy programs, virtual reality-based pain distraction and rehabilitation modules, augmented reality-guided movement therapy and posture training, artificial intelligence-driven personalization of therapy content and pacing, and natural language processing-powered coaching and symptom triage.

What Is The Digital Therapeutics For Fibromyalgia Market Size 2025 And Growth Rate?

The digital therapeutics for fibromyalgia market size has grown exponentially in recent years. It will grow from $0.98 billion in 2024 to $1.19 billion in 2025 at a compound annual growth rate (CAGR) of 21.3%. The growth in the historic period can be attributed to growing clinical recognition of fibromyalgia and earlier diagnosis, a shift to home-based self-management during the coronavirus pandemic, insurer and employer preference for nonpharmacological pain management, opioid stewardship policies favoring behavioral pain therapies, and rising patient preference for non-drug low-risk pain interventions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Digital Therapeutics For Fibromyalgia Market Segmented?

1) By Product Type: Software Applications, Devices, Platforms

2) By Therapy Area: cognitive behavioral therapy, Mindfulness-Based Interventions, Pain Management, Other Therapy Types

3) By Distribution Channel: Online, Offline

4) By Application: Chronic Pain Management, Sleep Disorders, Fatigue Management, Other Applications

5) By End-User: Hospitals, Clinics, Homecare, Other End-Users

Subsegments:

1) By Software Applications: Mobile Applications, Web-Based Applications, Cloud-Based Applications, Virtual Reality Applications

2) By Devices: Wearable Devices, Handheld Devices, Smart Monitoring Devices, Connected Therapeutics Devices

3) By Platforms: Telehealth Platforms, Remote Monitoring Platforms, Patient Engagement Platforms, Data Analytics Platforms

What Is Driving The Digital Therapeutics For Fibromyalgia Market? The Growing Awareness Of Digital Health Solutions Is Fueling The Growth Of The Market Due To Government-Backed Promotion And Widespread Adoption Of Official Health Apps

The growing awareness of digital health solutions are expected to propel the growth of the digital therapeutics for fibromyalgia market going forward. Digital health solutions are software-enabled tools and services such as patient apps, patient portals, and virtual-care platforms that deliver information, monitoring, and therapy through digital channels. The increasing awareness of digital health solutions is due to government-backed promotion and widespread adoption of official health apps that normalize online access to care. Digital therapeutics for fibromyalgia leverage this awareness by meeting patients in those familiar channels, streamlining onboarding and adherence to app-based cognitive behavioral therapy, pacing, and sleep programs while enabling clinician oversight. For instance, in December 2023, according to the National Health Service, a UK-based government department, digital health app users reached 33.6 million, up from 16.8 million in 2022, with monthly logins rising 54% from 16.8 million to 25.8 million. Therefore, the growing awareness of digital health solutions is driving the digital therapeutics for fibromyalgia industry.

Who Are The Major Players In The Global Digital Therapeutics For Fibromyalgia Market?

Major companies operating in the digital therapeutics for fibromyalgia market are Grünenthal GmbH, Hinge Health Inc., DarioHealth Corp., Kaia Health, CogniFit Inc., Big Health Ltd., Remedee Labs, HelloBetter GmbH, AppliedVR Inc., PainDrainer, Swing Therapeutics Inc., Fern Health Inc., JOGO Health Inc., LIN Health Inc., MoreGoodDays, Happify Health Inc., Click Therapeutics Inc., Wellthy Therapeutics Pvt. Ltd., FlexifyMe, SleepioRx.

What Are The Key Trends Of The Global Digital Therapeutics For Fibromyalgia Market? Prescription-Based Digital Therapeutics And Remote Monitoring For Enhanced Treatment

Major companies operating in the digital therapeutics for fibromyalgia market are focusing on technological advancements such as computerized behavioral therapy devices to deliver evidence-based interventions that improve pain management, reduce fatigue, enhance sleep quality, and support mental health, all through scalable, patient-centric digital platforms. A computerized behavioral therapy device refers to a software-based digital platform or application that delivers structured, evidence-based cognitive or behavioral therapy interventions to patients remotely, often using interactive modules, exercises, and real-time feedback to manage symptoms of conditions such as fibromyalgia. For instance, in May 2023, Swing Therapeutics, Inc., a US-based biopharmaceutical company, launched Stanza following U.S. FDA De Novo marketing authorization (DEN220083). It delivers a 12-week, self-guided acceptance and commitment therapy (ACT) program for fibromyalgia, with a randomized controlled trial in the lancet reporting significant clinical improvements. This is delivered via smartphone (iOS or Android), and meets patients in-app for convenient, at-home therapy.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Digital Therapeutics For Fibromyalgia Market? Xrhealth Acquires Realizedcare To Expand Artificial Intelligence(AI)-Driven Therapeutic XR And Chronic-Pain Digital Therapeutics

In February 2025, XRHealth Inc., a US-based therapeutic extended reality (XR) and digital-therapeutics company, acquired RealizedCare for an undisclosed amount. With this acquisition, XRHealth aims to integrate RealizedCare’s immersive digital-therapeutics content and artificial intelligence triage tool into its platform to broaden evidence-based care for chronic pain and behavioral health, including XRHealth’s existing fibromyalgia programs, while scaling artificial intelligence-enabled, value-based delivery and strengthening clinician oversight and personalization. RealizedCare is a US-based immersive digital-therapeutics company focused on chronic pain and behavioral health.

What Is The Regional Outlook For The Global Digital Therapeutics For Fibromyalgia Market?

North America was the largest region in the digital therapeutics for fibromyalgia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the Digital Therapeutics For Fibromyalgia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Digital Therapeutics For Fibromyalgia Market?

The digital therapeutics for fibromyalgia market consists of revenues earned by entities by providing services such as remote health coaching and therapist support, tele-physiotherapy consultations, adherence and engagement services, and outcomes analytics and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital therapeutics for fibromyalgia market also includes sales of cognitive behavioral therapy (cbt) apps, pain neuroscience education modules, digital graded exercise and activity pacing programs, virtual reality-based pain distraction experiences, and sleep hygiene and relaxation programs, clinician dashboards and care coordination tools, patient. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Digital Therapeutics For Fibromyalgia Industry?

The digital therapeutics for fibromyalgia market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics for fibromyalgia industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Table Of Contents

1. Executive Summary

2. Digital Therapeutics For Fibromyalgia Market Characteristics

3. Digital Therapeutics For Fibromyalgia Market Trends And Strategies

4. Digital Therapeutics For Fibromyalgia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Digital Therapeutics For Fibromyalgia Growth Analysis And Strategic Analysis Framework

5.1. Global Digital Therapeutics For Fibromyalgia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Digital Therapeutics For Fibromyalgia Market Growth Rate Analysis

5.4. Global Digital Therapeutics For Fibromyalgia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Digital Therapeutics For Fibromyalgia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Digital Therapeutics For Fibromyalgia Total Addressable Market (TAM)

6. Digital Therapeutics For Fibromyalgia Market Segmentation

6.1. Global Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Software Applications

Devices

Platforms

6.2. Global Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cognitive Behavioral Therapy

Mindfulness-Based Interventions

Pain Management

Other Therapy Types

6.3. Global Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Online

Offline

6.4. Global Digital Therapeutics For Fibromyalgia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chronic Pain Management

Sleep Disorders

Fatigue Management

Other Applications

6.5. Global Digital Therapeutics For Fibromyalgia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Homecare

Other End-Users

6.6. Global Digital Therapeutics For Fibromyalgia Market, Sub-Segmentation Of Software Applications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mobile Applications

Web-Based Applications

Cloud-Based Applications

Virtual Reality Applications

6.7. Global Digital Therapeutics For Fibromyalgia Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Wearable Devices

Handheld Devices

Smart Monitoring Devices

Connected Therapeutics Devices

6.8. Global Digital Therapeutics For Fibromyalgia Market, Sub-Segmentation Of Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Telehealth Platforms

Remote Monitoring Platforms

Patient Engagement Platforms

Data Analytics Platforms

7. Digital Therapeutics For Fibromyalgia Market Regional And Country Analysis

7.1. Global Digital Therapeutics For Fibromyalgia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Digital Therapeutics For Fibromyalgia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Digital Therapeutics For Fibromyalgia Market

8.1. Asia-Pacific Digital Therapeutics For Fibromyalgia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Digital Therapeutics For Fibromyalgia Market

9.1. China Digital Therapeutics For Fibromyalgia Market Overview

9.2. China Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Digital Therapeutics For Fibromyalgia Market

10.1. India Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Digital Therapeutics For Fibromyalgia Market

11.1. Japan Digital Therapeutics For Fibromyalgia Market Overview

11.2. Japan Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Digital Therapeutics For Fibromyalgia Market

12.1. Australia Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Digital Therapeutics For Fibromyalgia Market

13.1. Indonesia Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Digital Therapeutics For Fibromyalgia Market

14.1. South Korea Digital Therapeutics For Fibromyalgia Market Overview

14.2. South Korea Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Digital Therapeutics For Fibromyalgia Market

15.1. Western Europe Digital Therapeutics For Fibromyalgia Market Overview

15.2. Western Europe Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Digital Therapeutics For Fibromyalgia Market

16.1. UK Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Digital Therapeutics For Fibromyalgia Market

17.1. Germany Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Digital Therapeutics For Fibromyalgia Market

18.1. France Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Digital Therapeutics For Fibromyalgia Market

19.1. Italy Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Digital Therapeutics For Fibromyalgia Market

20.1. Spain Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Digital Therapeutics For Fibromyalgia Market

21.1. Eastern Europe Digital Therapeutics For Fibromyalgia Market Overview

21.2. Eastern Europe Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Digital Therapeutics For Fibromyalgia Market

22.1. Russia Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Digital Therapeutics For Fibromyalgia Market

23.1. North America Digital Therapeutics For Fibromyalgia Market Overview

23.2. North America Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Digital Therapeutics For Fibromyalgia Market

24.1. USA Digital Therapeutics For Fibromyalgia Market Overview

24.2. USA Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Digital Therapeutics For Fibromyalgia Market

25.1. Canada Digital Therapeutics For Fibromyalgia Market Overview

25.2. Canada Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Digital Therapeutics For Fibromyalgia Market

26.1. South America Digital Therapeutics For Fibromyalgia Market Overview

26.2. South America Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Digital Therapeutics For Fibromyalgia Market

27.1. Brazil Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Digital Therapeutics For Fibromyalgia Market

28.1. Middle East Digital Therapeutics For Fibromyalgia Market Overview

28.2. Middle East Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Digital Therapeutics For Fibromyalgia Market

29.1. Africa Digital Therapeutics For Fibromyalgia Market Overview

29.2. Africa Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Digital Therapeutics For Fibromyalgia Market Competitive Landscape And Company Profiles

30.1. Digital Therapeutics For Fibromyalgia Market Competitive Landscape

30.2. Digital Therapeutics For Fibromyalgia Market Company Profiles

30.2.1. Grünenthal GmbH Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Hinge Health Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. DarioHealth Corp. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Kaia Health Overview, Products and Services, Strategy and Financial Analysis

30.2.5. CogniFit Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Digital Therapeutics For Fibromyalgia Market Other Major And Innovative Companies

31.1. Big Health Ltd.

31.2. Remedee Labs

31.3. HelloBetter GmbH

31.4. AppliedVR Inc.

31.5. PainDrainer

31.6. Swing Therapeutics Inc.

31.7. Fern Health Inc.

31.8. JOGO Health Inc.

31.9. LIN Health Inc.

31.10. MoreGoodDays

31.11. Happify Health Inc.

31.12. Click Therapeutics Inc.

31.13. Wellthy Therapeutics Pvt. Ltd.

31.14. FlexifyMe

31.15. SleepioRx

32. Global Digital Therapeutics For Fibromyalgia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Digital Therapeutics For Fibromyalgia Market

34. Recent Developments In The Digital Therapeutics For Fibromyalgia Market

35. Digital Therapeutics For Fibromyalgia Market High Potential Countries, Segments and Strategies

35.1 Digital Therapeutics For Fibromyalgia Market In 2029 - Countries Offering Most New Opportunities

35.2 Digital Therapeutics For Fibromyalgia Market In 2029 - Segments Offering Most New Opportunities

35.3 Digital Therapeutics For Fibromyalgia Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Digital Therapeutics For Fibromyalgia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Digital Therapeutics For Fibromyalgia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Digital Therapeutics For Fibromyalgia Market, Sub-Segmentation Of Software Applications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Digital Therapeutics For Fibromyalgia Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Digital Therapeutics For Fibromyalgia Market, Sub-Segmentation Of Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Digital Therapeutics For Fibromyalgia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Digital Therapeutics For Fibromyalgia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Grünenthal GmbH Financial Performance
  • Table 80: Hinge Health Inc. Financial Performance
  • Table 81: DarioHealth Corp. Financial Performance
  • Table 82: Kaia Health Financial Performance
  • Table 83: CogniFit Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Digital Therapeutics For Fibromyalgia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Digital Therapeutics For Fibromyalgia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Digital Therapeutics For Fibromyalgia Market, Sub-Segmentation Of Software Applications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Digital Therapeutics For Fibromyalgia Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Digital Therapeutics For Fibromyalgia Market, Sub-Segmentation Of Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Digital Therapeutics For Fibromyalgia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Digital Therapeutics For Fibromyalgia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Grünenthal GmbH Financial Performance
  • Figure 80: Hinge Health Inc. Financial Performance
  • Figure 81: DarioHealth Corp. Financial Performance
  • Figure 82: Kaia Health Financial Performance
  • Figure 83: CogniFit Inc. Financial Performance

Frequently Asked Questions

Digital therapeutics for fibromyalgia are health apps and online programs that deliver structured therapy and track symptoms to support day-to-day self-management. Its purpose is to ease pain and fatigue, improve sleep and function, and give patients and clinicians useful data to personalize care. For further insights on this market, request a sample here

The market major growth driver - The Growing Awareness Of Digital Health Solutions Is Fueling The Growth Of The Market Due To Government-Backed Promotion And Widespread Adoption Of Official Health Apps. For further insights on this market, request a sample here

The digital therapeutics for fibromyalgia market size has grown exponentially in recent years. It will grow from $0.98 billion in 2024 to $1.19 billion in 2025 at a compound annual growth rate (CAGR) of 21.3%. The growth in the historic period can be attributed to growing clinical recognition of fibromyalgia and earlier diagnosis, a shift to home-based self-management during the coronavirus pandemic, insurer and employer preference for nonpharmacological pain management, opioid stewardship policies favoring behavioral pain therapies, and rising patient preference for non-drug low-risk pain interventions. The digital therapeutics for fibromyalgia market size is expected to see exponential growth in the next few years. It will grow to $2.54 billion in 2029 at a compound annual growth rate (CAGR) of 20.9%. The growth in the forecast period can be attributed to expansion of reimbursement for evidence-based digital interventions, rising integration into rheumatology and primary care pathways, rising prevalence and symptom burden in aging populations, greater focus on women’s health and chronic pain equity, and cost-containment pressure to reduce unnecessary imaging and visits. Major trends in the forecast period include prescription digital therapeutics delivering acceptance and commitment therapy programs, virtual reality-based pain distraction and rehabilitation modules, augmented reality-guided movement therapy and posture training, artificial intelligence-driven personalization of therapy content and pacing, and natural language processing-powered coaching and symptom triage. For further insights on this market, request a sample here

The digital therapeutics for fibromyalgiamarket covered in this report is segmented –
1) By Product Type: Software Applications, Devices, Platforms
2) By Therapy Area: Cognitive Behavioral Therapy, Mindfulness-Based Interventions, Pain Management, Other Therapy Types
3) By Distribution Channel: Online, Offline
4) By Application: Chronic Pain Management, Sleep Disorders, Fatigue Management, Other Applications
5) By End-User: Hospitals, Clinics, Homecare, Other End-Users Subsegments:
1) By Software Applications: Mobile Applications, Web-Based Applications, Cloud-Based Applications, Virtual Reality Applications
2) By Devices: Wearable Devices, Handheld Devices, Smart Monitoring Devices, Connected Therapeutics Devices
3) By Platforms: Telehealth Platforms, Remote Monitoring Platforms, Patient Engagement Platforms, Data Analytics Platforms For further insights on this market,
request a sample here

North America was the largest region in the digital therapeutics for fibromyalgia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the digital therapeutics for fibromyalgia market are Grünenthal GmbH, Hinge Health Inc., DarioHealth Corp., Kaia Health, CogniFit Inc., Big Health Ltd., Remedee Labs, HelloBetter GmbH, AppliedVR Inc., PainDrainer, Swing Therapeutics Inc., Fern Health Inc., JOGO Health Inc., LIN Health Inc., MoreGoodDays, Happify Health Inc., Click Therapeutics Inc., Wellthy Therapeutics Pvt. Ltd., FlexifyMe, SleepioRx.. For further insights on this market, request a sample here.

Major trends in this market include Prescription-Based Digital Therapeutics And Remote Monitoring For Enhanced Treatment. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon